23 July 2026
DLA Piper advises Kira Pharmaceuticals on merger with Jasper Therapeutics
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Fahd Riaz | DLA Piper | Partner | Not stated | Philadelphia |
| Dylan Caplan | DLA Piper | Partner | Not stated | Philadelphia |
| Patrick O'Malley | DLA Piper | Partner | Not stated | San Diego |
| James McGraw | DLA Piper | Partner | Not stated | Washington, DC |
| Rita Patel | DLA Piper | Partner | Not stated | Washington, DC |
| Patrick Cullen | DLA Piper | Associate | Not stated | Philadelphia |
| Shai Wood | DLA Piper | Associate | Not stated | Philadelphia |
| Tom Hauk | DLA Piper | Associate | Not stated | Philadelphia |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 132m (US$132 million)
- What the figure measures
- Facility amount
- Client
- Kira PharmaceuticalsBuy-side
- Counterparties
- Jasper Therapeutics (Sell-side)
Mirador Therapeutics (Investor)